MedTrace Logo

A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes

NCT00002293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-10-02

No results posted yet for this study

Summary

To determine a safe, effective, and convenient dosing schedule for nystatin pastilles in the prophylaxis of oral candidiasis in patients with AIDS or AIDS related syndromes (group III or IV, CDC classification)

Conditions

  • Candidiasis, Oral
  • HIV Infections

Interventions

DRUG

Nystatin

Sponsors & Collaborators

Study Design

Purpose
TREATMENT

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002293 on ClinicalTrials.gov